Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.725 USD | +2.34% | -2.34% | -34.15% |
May. 07 | Transcript : AbCellera Biologics Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | AbCellera Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.15% | 1.07B | |
+43.22% | 50.93B | |
-0.41% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.08% | 26.02B | |
-21.89% | 18.9B | |
+7.83% | 13.21B | |
+24.07% | 12.17B | |
+30.39% | 12.16B |
- Stock Market
- Equities
- ABCL Stock
- News AbCellera Biologics Inc.
- Piper Sandler Trims Price Target on AbCellera Biologics to $21 From $22, Maintains Overweight Rating